Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced an oral presentation at the upcoming ...

In what could mark a historic leap in medical science, researchers are now closer than ever to developing a CRISPR-based therapy capable of cutting the HIV virus directly out of a patient’s genome — ...

Just in case the idea of aliens walking around in human skin suits wasn’t frightening enough. An outlandish study asserts that aliens might have abducted us and inserted genes into human DNA, with the ...

The Nobel Prize winner in Medicine is investigating genetic changes that could have given our species a competitive advantage, and the possibility of extracting the genome of the Flores hobbit ...

A researcher claims to have found evidence of what might be alien genetic manipulation of human beings, with large sections of DNA seemingly 'inserted' into people.

The company is gene editing crops to make our food supply more resilient to climate change.

A man with type 1 diabetes produced his own insulin after receiving genetically edited donor cells, and he did it without taking drugs that shut down the immune system. Type 1 diabetes happens when ...

AstraZeneca has signed a $555 million deal with a San Francisco-based biotech business Algen Biotechnologies, The Financial Times reported on Monday. The agreement with Algen gives AstraZeneca ...

G lobal pharmaceutical giant AstraZeneca has penned a $555 million with Algen Biotechnologies, a San Francisco-based biotechnology business that specialises in artificial intelligence, reports ...

Arbor will receive $115 million in upfront and near-term payments and be eligible for up to $2 billion in milestone payments and tiered royalties.